• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝门部胆管癌的腹腔镜分期:是否仍有必要?

Staging laparoscopy for hilar cholangiocarcinoma: is it still worthwhile?

机构信息

Department of Surgery, Academic Medical Centre, Amsterdam, The Netherlands.

出版信息

Ann Surg Oncol. 2011 Sep;18(9):2647-53. doi: 10.1245/s10434-011-1576-8. Epub 2011 Feb 23.

DOI:10.1245/s10434-011-1576-8
PMID:21347792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3162633/
Abstract

PURPOSE

This study was designed to evaluate the benefit of staging laparoscopy (SL) in patients with suspected hilar cholangiocarcinoma (HCCA) during the past 10 years. Only 50-60% of patients with HCCA who undergo laparotomy are ultimately amenable to a potentially curative resection. In a previous study, we recommended routine use of SL to prevent unnecessary laparotomies. The accuracy of imaging techniques, however, has significantly improved during the past decade, which is likely to impact the yield and accuracy of SL.

METHODS

From 2000 to 2010, 195 patients with suspected HCCA were analyzed. The yield and accuracy of SL were calculated by dividing total number of avoided laparotomies by the total number of laparoscopies or by all patients with unresectable disease, respectively. Factors associated with better yield and accuracy were assessed.

RESULTS

Of 195 patients with HCCA, 175 underwent SL. The yield of SL was 14% and the accuracy was 32%. Operative morbidity of SL was 3%, and operative morbidity of laparotomy for unresectable disease was 33%. No clear factors that influenced the yield of SL were found.

CONCLUSION

Overall yield and accuracy of SL for HCCA in the present series decreased to 14% and 32%, respectively, compared with earlier reports. This finding is likely the result of improved imaging techniques that evolved during the past decade. The place of SL in the workup of patients with HCCA needs to be reconsidered, and one should decide whether the declining additional value of SL still outweighs the drawbacks of SL.

摘要

目的

本研究旨在评估过去 10 年中对疑似肝门部胆管癌(HCCA)患者进行分期腹腔镜检查(SL)的获益。仅 50-60%接受剖腹手术的 HCCA 患者最终可接受潜在治愈性切除。在之前的研究中,我们建议常规使用 SL 以防止不必要的剖腹手术。然而,过去十年中成像技术的准确性有了显著提高,这可能会影响 SL 的检出率和准确性。

方法

从 2000 年到 2010 年,分析了 195 例疑似 HCCA 患者。通过将避免剖腹手术的总例数除以总腹腔镜例数或所有不可切除疾病患者数,计算 SL 的检出率和准确性。评估与更好的检出率和准确性相关的因素。

结果

在 195 例 HCCA 患者中,175 例行 SL。SL 的检出率为 14%,准确性为 32%。SL 的手术发病率为 3%,不可切除疾病的剖腹手术发病率为 33%。未发现明显影响 SL 检出率的因素。

结论

与早期报道相比,本研究中 SL 对 HCCA 的总体检出率和准确性分别降至 14%和 32%。这一发现可能是过去十年中成像技术不断发展的结果。在 HCCA 患者的检查中,SL 的位置需要重新考虑,人们应该判断 SL 不断下降的附加价值是否仍然超过 SL 的缺点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d0/3162633/dc9efc0952c6/10434_2011_1576_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d0/3162633/dc9efc0952c6/10434_2011_1576_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9d0/3162633/dc9efc0952c6/10434_2011_1576_Fig1_HTML.jpg

相似文献

1
Staging laparoscopy for hilar cholangiocarcinoma: is it still worthwhile?肝门部胆管癌的腹腔镜分期:是否仍有必要?
Ann Surg Oncol. 2011 Sep;18(9):2647-53. doi: 10.1245/s10434-011-1576-8. Epub 2011 Feb 23.
2
Staging laparoscopy for hilar cholangiocarcinoma in 100 patients.对 100 例肝门部胆管癌患者行腹腔镜分期。
Langenbecks Arch Surg. 2013 Oct;398(7):983-8. doi: 10.1007/s00423-013-1104-3. Epub 2013 Sep 1.
3
Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients.肝外胆管癌患者的分期腹腔镜检查。100例患者的分析。
Ann Surg. 2002 Mar;235(3):392-9. doi: 10.1097/00000658-200203000-00011.
4
The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma.腹腔镜评估在疑似肝门部胆管癌术前分期中的应用。
J Gastrointest Surg. 2005 Apr;9(4):476-80. doi: 10.1016/j.gassur.2004.10.009.
5
Laparoscopic staging in hilar cholangiocarcinoma: Is it still justified?腹腔镜肝门部胆管癌分期:是否仍有必要?
World J Gastrointest Oncol. 2013 Jul 15;5(7):127-31. doi: 10.4251/wjgo.v5.i7.127.
6
FDG-positron emission tomography/computed tomography and standardized uptake value in the primary diagnosis and staging of hilar cholangiocarcinoma.正电子发射断层扫描/计算机断层扫描和标准化摄取值在肝门部胆管癌的原发诊断和分期中的应用。
HPB (Oxford). 2011 Apr;13(4):256-62. doi: 10.1111/j.1477-2574.2010.00280.x. Epub 2011 Mar 7.
7
Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma.专门的多学科方法和综合途径对肝门部胆管癌结局的影响。
Eur J Surg Oncol. 2014 Jan;40(1):77-84. doi: 10.1016/j.ejso.2013.10.009. Epub 2013 Oct 23.
8
Diagnostic role of staging laparoscopy in a subset of biliary cancers: a meta-analysis.分期腹腔镜检查在部分胆管癌中的诊断作用:一项荟萃分析。
ANZ J Surg. 2017 Jan;87(1-2):22-27. doi: 10.1111/ans.13762. Epub 2016 Sep 20.
9
Development of a Risk Score to Predict Detection of Metastasized or Locally Advanced Perihilar Cholangiocarcinoma at Staging Laparoscopy.用于预测分期腹腔镜检查时转移性或局部进展期肝门周围胆管癌检出情况的风险评分系统的开发。
Ann Surg Oncol. 2016 Dec;23(Suppl 5):904-910. doi: 10.1245/s10434-016-5531-6. Epub 2016 Sep 1.
10
Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.胆囊癌和肝门胆管癌切除术后的初始疾病复发模式:对辅助治疗策略的启示
Cancer. 2003 Oct 15;98(8):1689-700. doi: 10.1002/cncr.11699.

引用本文的文献

1
British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma.英国胃肠病学会胆管癌诊断和管理指南。
Gut. 2023 Dec 7;73(1):16-46. doi: 10.1136/gutjnl-2023-330029.
2
Predictive model for the intraoperative unresectability of hilar cholangiocarcinoma: Reducing futile surgical exploration.预测肝门部胆管癌术中不可切除性的模型:减少无效的手术探查。
PLoS One. 2022 Apr 13;17(4):e0258522. doi: 10.1371/journal.pone.0258522. eCollection 2022.
3
Effect of vascular resection for perihilar cholangiocarcinoma: a systematic review and meta-analysis.

本文引用的文献

1
Hilar cholangiocarcinoma: current management.肝门部胆管癌:当前的治疗方法
Ann Surg. 2009 Aug;250(2):210-8. doi: 10.1097/SLA.0b013e3181afe0ab.
2
Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.18F-FDG PET-CT在疑似及可能可手术切除的胆管癌中的临床作用:一项与传统成像对比的前瞻性研究
Am J Gastroenterol. 2008 May;103(5):1145-51. doi: 10.1111/j.1572-0241.2007.01710.x. Epub 2008 Jan 2.
3
Utility of staging laparoscopy in subsets of biliary cancers : laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma.
肝门部胆管癌血管切除的效果:一项系统评价和Meta分析
PeerJ. 2021 Sep 23;9:e12184. doi: 10.7717/peerj.12184. eCollection 2021.
4
Current Surgical Management of Peri-Hilar and Intra-Hepatic Cholangiocarcinoma.肝门周围及肝内胆管癌的当前外科治疗
Cancers (Basel). 2021 Jul 21;13(15):3657. doi: 10.3390/cancers13153657.
5
Diagnostic Approach to Suspected Perihilar Malignancy.疑似肝门部恶性肿瘤的诊断方法
Visc Med. 2021 Feb;37(1):3-9. doi: 10.1159/000513950. Epub 2021 Jan 19.
6
The Clinical Management of Cholangiocarcinoma in the United States and Europe: A Comprehensive and Evidence-Based Comparison of Guidelines.美国和欧洲胆管癌的临床管理:指南的全面循证比较
Ann Surg Oncol. 2021 May;28(5):2660-2674. doi: 10.1245/s10434-021-09671-y. Epub 2021 Mar 1.
7
Current Advances in Minimally Invasive Surgical Management of Perihilar Cholangiocarcinoma.当前微创治疗肝门部胆管癌的进展。
J Gastrointest Surg. 2020 Sep;24(9):2143-2149. doi: 10.1007/s11605-020-04639-x. Epub 2020 May 14.
8
Management Strategies for Patients with Hilar Cholangiocarcinomas: Challenges and Solutions.肝门部胆管癌患者的管理策略:挑战与解决方案
Hepat Med. 2020 Jan 23;12:1-13. doi: 10.2147/HMER.S223022. eCollection 2020.
9
Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutions.肝外胆管恶性肿瘤三种亚型的分期腹腔镜检查:来自10家机构的15年经验
J Surg Oncol. 2019 Mar;119(3):288-294. doi: 10.1002/jso.25323. Epub 2018 Dec 26.
10
Assessing resectability in cholangiocarcinoma.评估胆管癌的可切除性。
Hepat Oncol. 2014 Jan;1(1):39-51. doi: 10.2217/hep.13.6. Epub 2013 Dec 20.
分期腹腔镜检查在胆管癌亚组中的应用:腹腔镜检查是肝内癌和胆囊癌患者的一种强大诊断工具。
Surg Endosc. 2006 May;20(5):721-5. doi: 10.1007/s00464-005-0583-x. Epub 2006 Feb 27.
4
The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma.腹腔镜评估在疑似肝门部胆管癌术前分期中的应用。
J Gastrointest Surg. 2005 Apr;9(4):476-80. doi: 10.1016/j.gassur.2004.10.009.
5
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.手术并发症的分类:一项在6336例患者队列中进行评估的新提议及一项调查结果
Ann Surg. 2004 Aug;240(2):205-13. doi: 10.1097/01.sla.0000133083.54934.ae.
6
Endoscopic palliation of patients with biliary obstruction caused by nonresectable hilar cholangiocarcinoma: efficacy of self-expandable metallic Wallstents.不可切除性肝门部胆管癌所致胆道梗阻患者的内镜下姑息治疗:自膨式金属Wallstents支架的疗效
Gastrointest Endosc. 2002 Jul;56(1):33-9. doi: 10.1067/mge.2002.125364.
7
Diagnostic laparoscopy and laparoscopic ultrasound for staging of patients with malignant proximal bile duct obstruction.诊断性腹腔镜检查及腹腔镜超声用于恶性近端胆管梗阻患者的分期
J Gastrointest Surg. 2002 May-Jun;6(3):426-30; discussion 430-1. doi: 10.1016/s1091-255x(02)00005-7.
8
Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients.肝外胆管癌患者的分期腹腔镜检查。100例患者的分析。
Ann Surg. 2002 Mar;235(3):392-9. doi: 10.1097/00000658-200203000-00011.
9
Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies.分期腹腔镜检查在胰腺周围和胆道恶性肿瘤亚组中的应用价值。
Ann Surg. 2002 Jan;235(1):1-7. doi: 10.1097/00000658-200201000-00001.
10
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.225例肝门部胆管癌患者的分期、可切除性及预后
Ann Surg. 2001 Oct;234(4):507-17; discussion 517-9. doi: 10.1097/00000658-200110000-00010.